Products for Research Use Only
RegisterLogin

Apatinib (YN968D1) mesylate

CAT: 1568-C16707-01Size: 10 mM / 1 mLDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:1568-C16707-01Size:10 mM / 1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1218779-75-9
Synonyms
YN968D1, Rivoceranib
SKU
C16707-200mg
Target
VEGFR
Applications
Protein Tyrosine Kinase
Smiles
C[S] (O) (=O) =O.O=C (NC1=CC=C (C=C1) C2 (CCCC2) C#N) C3=CC=CN=C3NCC4=CC=NC=C4
Molecular Formula
C25H27N5O4S
Additionnal Information
Apatinib mesylate (YN968D1, Rivoceranib) is a potent inhibitor of the VEGF signaling pathway with IC50 values of 1 nM, 13 nM, 429 nM and 530 nM for VEGFR-2, Ret (c-Ret), c-Kit and c-Src, respectively. Apatinib mesylate induces both autophagy and apoptosis.
Storage Conditions
2 years -80 in solvent

Chemical Information

Rivoceranib Mesylate

Rivoceranib Mesylate is the mesylate salt of rivoceranib, an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.

CAS Number1218779-75-9
PubChem CID45139106
IUPAC NameN-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acid
Molecular FormulaC25H27N5O4S
Molecular Weight493.6
Topological Polar Surface Area153
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Heavy Atom Count35
Formal Charge0
Complexity701
SMILES
CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4
InChI
InChI=1S/C24H23N5O.CH4O3S/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18;1-5(2,3)4/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30);1H3,(H,2,3,4)
InChIKey
FYJROXRIVQPKRY-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Rivoceranib Mesylate
CAS: 1218779-75-9
CID: 45139106
Formula: C25H27N5O4S
MW: 493.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight493.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass493.17837553
Monoisotopic Mass493.17837553
Topological Polar Surface Area153 Ų
Heavy Atom Count35
Formal Charge0
Complexity701
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
C10843-2gApatinib
C10843-1gApatinib
C10843-25mgApatinib
C10843-01Apatinib
C10843-100mgApatinib
C10843-5mgApatinib
C01340Gemifloxacin mesylate
C09077-10mgDanofloxacin Mesylate
C17228-10mM/1mLBenztropine mesylate
C10081-10mgNelfinavir Mesylate

Alternative Products

CatalogName
S2221-10mgApatinib (YN968D1) mesylate
MBS130190-01Apatinib (YN968D1)
200135Apatinib mesylate
A11407-10mM-DApatinib (YN968D1) 10mM * 1mL in DMSO
RM-A271002-01Apatinib Mesylate Impurity 2
RM-A271005-01Apatinib Mesylate Impurity 5
RM-A271004-01Apatinib Mesylate Impurity 4
RM-A271006-01Apatinib Mesylate Impurity 6
RM-A271007-01Apatinib Mesylate Impurity 7
RM-A271001-01Apatinib Mesylate Impurity 1

Popular Products